BioHarvest Sciences (TSE:BHSC) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
BioHarvest Sciences reported a remarkable 101% increase in revenue for Q3 2024, reaching over $6.5 million, surpassing management’s expectations. The company’s gross margins improved significantly, and they successfully uplisted to the Nasdaq Global Market. Their VINIA® product line, including a new SuperFood tea, contributed to strong growth and customer expansion.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
